Acadia Pharmaceuticals Inc.

Go to Acadia Pharmaceuticals Inc. Website

$23.55

-0.09 (-0.40%)
Live
Previous Close

$23.64

Day Range

$23.35 - $23.84

Previous Day Range

$23.46 - $24.1699

Market Cap

$4.0 billion USD

Day Vol.

169180

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

Nasdaq

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuros...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The Parkinson's disease market is expected to grow significantly due to the introduction of emerging therapies, advancements in treatment options, and a rising prevalence of the condition.

Related tickers: ACAD, AMRX, MGTX, LLY, SMDPY.

Read Full Article

The global neuroregeneration therapy market is expected to grow significantly, driven by advancements in regenerative medicine and the rising prevalence of neurological disorders. Key players are investing heavily in R&D, leading to innovative therapies and clinical trials that are accelerating market expansion.

Related tickers: BIIB, MRK, NVS, TEVA, ACAD, MTLHY, DNLI, UCBJY, HLBAY.

Read Full Article
Trending Tickers

Please sign in to view